The Indian pharmaceutical sector is well-positioned to capitalize on Bahrain's growing demand for generic medications. With a total export value of $22.5 million in 2022, Indian exporters have established a solid presence in the Bahraini market, with 136 exporters supplying 3,175 shipments to 166 Bahrain-based buyers. The average shipment value stands at $7,000, indicating a diverse range of products and transaction sizes.
The top 10 products exported to Bahrain include medical appliances and human immunoglobulins, highlighting the demand for both medical devices and specialized biologics. Notably, Dynamic Techno Medicals Private Limited leads with $6.6 million in exports, followed by Reliance Life Sciences Private Limited at $4.8 million. These figures suggest a strong foothold in both the medical device and pharmaceutical segments.
Looking ahead, the forecasted growth in Bahrain's pharmaceutical market, coupled with the increasing acceptance of generic drugs, presents a promising opportunity for Indian exporters. By focusing on high-demand therapeutic areas such as oncology, cardiology, and immunology, Indian pharmaceutical companies can expand their market share. Additionally, aligning with Bahrain's regulatory standards and participating in government initiatives aimed at enhancing healthcare infrastructure can further strengthen the position of Indian exporters in this growing market.
